Compare SPRU & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPRU | STIM |
|---|---|---|
| Founded | 2008 | 2003 |
| Country | United States | United States |
| Employees | 4 | N/A |
| Industry | Auto Parts:O.E.M. | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.0M | 105.5M |
| IPO Year | 2019 | 2018 |
| Metric | SPRU | STIM |
|---|---|---|
| Price | $4.04 | $1.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 43.3K | ★ 1.8M |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.30 | 57.25 |
| EPS | N/A | ★ N/A |
| Revenue | $23,194,000.00 | ★ $52,776,000.00 |
| Revenue This Year | $2.12 | $11.51 |
| Revenue Next Year | N/A | $11.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 48.68 | N/A |
| 52 Week Low | $1.13 | $0.80 |
| 52 Week High | $6.75 | $4.84 |
| Indicator | SPRU | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 48.52 | 54.77 |
| Support Level | $3.92 | $1.22 |
| Resistance Level | $4.59 | $1.55 |
| Average True Range (ATR) | 0.35 | 0.20 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 47.06 | 84.71 |
Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.